SEC Form 4 · accession 0001214659-15-004224
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E. Thompson
Director
Period of report
May 21, 2015
Accepted (ET)
May 22, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.75 | May 21, 2015 | A | 28,846 | A | — | May 21, 2025 | Common Stock | 28,846 | 28,846 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of May 21, 2015. This stock option is fully exercisable on May 21, 2016.